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Background: Alcohol is a major global threat to public health. Although the main burden of chronic alcohol-related
disease is in adults, its foundations often lie in adolescence. Alcohol consumption and related harm increase steeply
from the age of 12 until 20 years. Several trials focusing upon young people have reported significant positive effects
of brief interventions on a range of alcohol consumption outcomes. A recent review of reviews also suggests that
electronic brief interventions (eBIs) using internet and smartphone technologies may markedly reduce alcohol
consumption compared with minimal or no intervention controls.
Interventions that target non-drinking youth are known to delay the onset of drinking behaviours. Web based
alcohol interventions for adolescents also demonstrate significantly greater reductions in consumption and
harm among ‘high-risk’ drinkers; however changes in risk status at follow-up for non-drinkers or low-risk
drinkers have not been assessed in controlled trials of brief alcohol interventions.
Design and methods: The study design comprises two linked randomised controlled trials to evaluate the
effectiveness and cost-effectiveness of two intervention strategies compared with screening alone. One trial
will focus on high-risk adolescent drinkers attending Emergency Departments (Eds) and the other will focus
on those identified as low-risk drinkers or abstinent from alcohol but attending the same ED.
Our primary (null) hypothesis is similar for both trials: Personalised Feedback and Brief Advice (PFBA) and Personalised
Feedback plus electronic Brief Intervention (eBI) are no more effective than screening alone in alcohol consumed at
12 months after randomisation as measured by the Time-Line Follow-Back 28-day version. Our secondary (null)
hypothesis relating to economics states that PFBA and eBI are no more cost-effective than screening alone.
In total 1,500 participants will be recruited into the trials, 750 high-risk drinkers and 750 low-risk drinkers or abstainers.
Participants will be randomised with equal probability, stratified by centre, to either a screening only control group or
one of the two interventions: single session of PFBA or eBI. All participants will be eligible to receive treatment as usual
in addition to any trial intervention. Individual participants will be followed up at 6 and 12 months after randomisation.
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Discussion: The protocol represents an ambitious innovative programme of work addressing alcohol use in the
adolescent population.
Trial registration: ISRCTN45300218. Registered 5th July 2014.
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Alcohol is a major global threat to public health [1]. Al-
though the main burden of chronic alcohol-related dis-
ease is in adults, its foundations often lie in adolescence
[2]. A recent survey of alcohol use among 14–15 year
olds across 36 European countries found that 87% re-
ported lifetime alcohol use, with 57% consuming alcohol
on one or more occasion in the previous month [3].
While the proportion of young people in England aged
11–15 years who reported that they have drunk alcohol
decreased from 62% to 45% between 1988 and 2011, the
mean amount consumed approximately doubled (from
6.4 to 10.4 units of alcohol per week) between 1994 and
2011 [4]. In England there is a rapid increase in alcohol
consumption during school years, with 1% of those
aged 11 years reporting weekly alcohol consumption
compared with 28% of those aged 15 years [4]. Adoles-
cents in the UK are now amongst the heaviest drinkers in
Europe [5].
Alcohol consumption and related harm increase steeply
from the age of 12 until 20 years [6]. In middle adoles-
cence (ages 15–17 years) binge drinking (single occasion
consumption leading to intoxication) often emerges. Binge
drinking is associated with increased risk of unprotected
or regretted sexual activity [3,5,7], criminal and disorderly
behaviour [5,8], suicide and deliberate self-harm [9], injury
[5], drink-driving or allowing oneself to be carried by a
drinking driver [10], alcohol poisoning [11] and accidental
death [12].
Over the past 15 years the World Health Organisation
(WHO), the US Surgeon General, the American Medical
Association, and the American Academy of Paediatrics
have called for practitioners to carry out screening and
brief interventions (SBI) for adolescent drinkers [13-16].
The alcohol strategies in both England and Scotland
identify adolescents as a key target group in whom to re-
duce alcohol consumption and related harm [8,17]. How-
ever, while there has been an increase in SBI activity in
relation to adults presenting to health care providers, ado-
lescents remain a neglected group.
The term Brief Intervention (BI) encompasses a range
of therapeutic processes from advice to extended coun-
selling, and typically is delivered in short sessions on
one or more occasion. A number of trials focusing upon
young people (aged 12 – 21) have reported significantpositive effects of brief interventions on a range of alco-
hol consumption measures [18-23]. Our recent review of
reviews suggests that internet and smartphone delivered
BIs (eBI) can significantly reduce alcohol consumption
compared with minimal or no intervention controls, and
have the added advantage of being more acceptable and
easier to implement than more traditional face-to-face
interventions [24,25]. Our recently completed study of the
prevalence of risky drinking among an adolescent popula-
tion (aged 10–17 years) found that about 1 in 4 young
people presenting to Emergency Departments (EDs) were
consuming three or more drinks on one or more occasion
over the preceding month, and that this level of consump-
tion was associated with increased physical, social and edu-
cational adverse consequences. We also observed a steep
transition in drinking prevalence between 13 and 16 years
of age.
Several school-based interventions that target non-
drinking youths have been found to delay the onset of
drinking behaviours [26] and a recent study of adoles-
cents found lower rates of substance misuse initiation
among those exposed to a web-based intervention [27].
Web-based alcohol interventions for adolescents also
demonstrated significantly greater reductions in consump-
tion and harm among ‘high-risk’ drinkers [28]; however
changes in risk status at follow up for non-drinkers or
low-risk drinkers have not been assessed in any well con-
trolled trials of BI. Therefore our proposed work will assess
both primary outcomes (delayed onset) and secondary out-
comes (reduction of consumption and associated harms in
those already drinking at a high level) among a population
of adolescents.
Recruitment of both ‘high-risk’ and ‘low-risk’ drinkers will
have the additional benefit of addressing a major concern
among both young people and parents that participation in
a trial of this nature may suggest that the participant is
drinking at a level that warrants concern and intervention.
Young people interviewed as part of this process indicated
that they would prefer to take part in a trial if there was no
implication that they had an “alcohol problem” and were
assured that information about their drinking would not be
disclosed to parents or healthcare staff.
Thus we shall conduct two linked trials that will in-
clude both high-risk and low-risk drinkers and abstainers,
informing them that the study seeks to prevent alcohol-
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within the proposed study is an internal feasibility study
conducted prior to proceeding to the main trial.
Objectives of the study
Two linked randomised controlled trials will be con-
ducted. Both trials will evaluate the effectiveness and cost-
effectiveness of BI intervention strategies compared with
screening alone. One trial will focus on high-risk adoles-
cent drinkers attending Emergency Departments and
the other will focus on those identified as low-risk or ab-
stinent from alcohol. In both trials our primary outcome
measure will be quantity of alcohol consumed at 12 months
after randomisation.
Secondary objectives for each study include:
 To identify key predictors of recruitment to the trials.
 To explore the process of treatment through key
psychological constructs that may lead to further
refinement of the proposed interventions.
 To identify prognostic factors that improve outcome.
 To explore interactions between participant factors,
setting factors, treatment allocation and outcomes.
Our primary (null) hypothesis is similar for both trials:
Personalised Feedback and Brief Advice (PFBA) and
Personalised Feedback plus electronic Brief Intervention
(eBI) are no more effective than screening alone in redu-
cing alcohol consumed at 12 months after randomisation
measured by the Time-Line Follow-Back 28-day version.
Our secondary (null) hypothesis relating to economics
states that PFBA and eBI are no more cost-effective than
screening alone.
Methods
The linked trials have been granted ethical approval by
the National Research Ethics Service London – Fulham
(ref: 14/LO/0721). The linked trials comply with theFigure 1 Trials flow chart.Declaration of Helsinki and Good Clinical Practice. Full
flow diagrams for the studies are shown in Figure 1.
Both trials begin with a randomised internal pilot study
to check that the process of recruitment, screening and
intervention is effective and does not adversely affect the
ED environment. If that pilot is successful, two linked pro-
spective individually randomised controlled trials will be
conducted using a similar design, measures and interven-
tions with 6 and 12 months follow up.
Study settings and participants
The trial will be carried out in 10 EDs across three regions
of England: North East, Yorkshire and Humberside, and
London. Data collection will be carried out from 10 am to
10 pm seven days per week over a six-month period. During
these hours of screening consecutive ED attenders between
their 14th and 18th birthdays who meet the inclusion cri-
teria but none of the exclusion criteria will be approached
by a researcher and invited to participate in the study once
cleared by ED staff to do so.
Eligibility criteria
Inclusion and exclusion criteria have been chosen to
maintain a balance between ensuring the sample is rep-
resentative of the ED population whilst able to engage
with both the relevant interventions and follow up.
Inclusion criteria for participants: aged between 14 and
17 years; alert and orientated; able to speak English suffi-
ciently well to complete the research assessment; resident
within 20 miles of the ED; able and willing to provide in-
formed consent to screening, intervention and follow-up;
if under 16 years, are ‘Gillick competent’ or have a parent
or guardian able and willing to provide informed consent;
and own a smartphone or alternatively having access to
the internet at home.
Exclusion criteria for participants: severe injury; suffering
from serious mental health problem; gross intoxication; spe-
cialist services involved because of social or psychological
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disorder within the past 6 months; or current participation
in other alcohol-related research.
Those who meet the inclusion criteria, fail no exclu-
sion criterion, and score 3 or more on the screening
questionnaire – Alcohol Use Disorders Identification
Test: Consumption (AUDIT-C) – are eligible for the high-
risk study; those who score less are eligible for the low-
risk study.
Consent procedure
The study will be introduced to patients, and their par-
ents or guardians if they are aged less than 16 years, as a
study about alcohol, lifestyle and health with the focus
on preventing alcohol-related harm in all young people
attending ED irrespective of their alcohol consumption.
Patients attending ED without their parent or guardian
will also be approached to take part if ED staff have con-
firmed that they are ‘Gillick competent’.
The study will be first introduced by ED staff and then
explained in more detail by research staff orally and in
writing using the Patient Information Sheet (PIS). If the
patient is under the age of 16 years and accompanied by
a parent or guardian, the parent or guardian will also re-
ceive the PIS. Patients, and parents or guardians if ap-
plicable, will have up to 4 hours to ask any questions
about the study and to decide whether or not to take
part. To obtain the most valid selfreport data patients
will be told as part of the informed consent procedure
that their answers, including alcohol consumption, will
not be disclosed to their parent or guardian or the ED
staff without their consent.
If patients agree to participate, informed consent will
be collected using an electronic device (iPad) overseen
by a research assistant who will also introduce and de-
liver the allocated intervention to each patient in a pri-
vate area of the ED. Consent to participate will include
permission to give the patient's data and contact details
to the research staff, and provide the research team with
access to the patient’s ED records, and to participate in
follow up 6 and 12 months after recruitment.
Screening and baseline assessment
After consent has been given, by parent or guardian if ap-
propriate, the participant will complete a screening and
baseline assessment. All participants scoring 3 or more on
the AUDIT-C questionnaire (high-risk drinkers) will be
randomised between three groups – two intervention
groups and the control group receiving screening alone.
Of those scoring less than 3 on the AUDIT-C (low-risk
drinkers or abstainers) one in three will be randomly se-
lected to continue with the study and then randomised
between three analogous groups. Participants who score
less than 3 but are not selected for the study will bethanked for their participation, given a £5 voucher and
returned to the care of ED staff.
The screening and baseline assessment includes demo-
graphic information and contact details, health and life-
style questions, the AUDIT-C [29], questions 19, 21 and
22 from the European School survey Project on Alcohol
and other Drugs (ESPAD) [5], the Strengths and Difficul-
ties Questionnaire [30], the EQ-5D-5 L [31], and a short
service use questionnaire [32]. This takes approximately
10 minutes to complete.
To simplify and enhance data collection we have devel-
oped an electronic interface which will only show relevant
questions to participants. To maximise completion rates
this interface uses an attractive graphic interface. Partici-
pants can skip questions or withdraw consent at any stage
of the process. All of the instruments have been designed
and validated for those aged 14 to 17. The screening and
baseline assessment will be conducted by trained re-
searchers with experience of working with adolescents; all
researchers will have completed enhanced Disclosure and
Barring Service checks in advance. All information given
by participants will be treated in confidence.
In total 1,500 participants will be recruited into the tri-
als, 750 high-risk alcohol users and 750 low-risk alcohol
users. Participants will be randomized with equal prob-
ability, stratified by centre, between a screening only con-
trol group and one of the two interventions – a single
session of facetoface Personalised Feedback and Brief
Advice (PFBA) or Personalised Feedback plus a smart-
phone or web-based brief intervention (eBI). All partici-
pants will be eligible to receive treatment as usual in
addition to any trial intervention.
Planned interventions
Screening only group – Treatment as Usual
After completing the baseline assessment, participants in
the screening arm will be thanked for their participation,
reminded that a member of the research team will con-
tact them in six and twelve months time to conduct a
follow-up interview, and returned to the care of ED staff
for usual care.
Personalised Feedback and Brief Advice (PFBA)
The PFBA intervention is structured brief advice that
will take approximately 5 minutes to deliver. It is based
upon an advice leaflet adapted for the target age group
in this study from the SIPS Brief Advice About Alcohol
Risk intervention [33,34]. It will be conveyed orally to the
participant, and tailored to their risk status – high or low.
The advice will cover recommended levels of alcohol con-
sumption for young people; summarise the screening re-
sults and their meaning; provide normative comparison
information on prevalence rates of high and low risk
drinking in young people; summarise the risks of drinking
Deluca et al. BMC Public Health  (2015) 15:345 Page 5 of 8and highlight the benefits of stopping or reducing alcohol
consumption; outline strategies that they might employ to
help stop or reduce alcohol consumption; and highlight
goals they might wish to consider; indicate where to ob-
tain further help if they are unsuccessful or need more
support. The participant will receive a copy of the leaflet,
which includes additional information about alcohol in-
toxication, alcohol poisoning, and alcohol and the law.
Personalised Feedback plus a smartphone or web based
brief intervention (eBI)
The eBI smartphone intervention is an offline capable
mobile web application that work on a variety of plat-
forms but has been optimised for recent iPhone and An-
droid phones. It has been developed using the concept of
gamification so users can navigate, explore, learn facts and
figures about alcohol, receive personalised feedback and
set goals in an engaging format. Its content will adapt to
provide the most pertinent information and advice for
high-risk or low-risk drinkers. Games components within
the web application will support high-risk drinkers to re-
duce or stop their alcohol consumption, and low-risk users
to maintain abstinence or low risk drinking.
For participants without access to a smartphone but
with access to the internet through other computerised
devices, access to a web based version of the application
will be provided with appropriate instructions on its use.
All participants after receiving their allocated interven-
tion (including the screening only group) will be thanked
for their participation, reminded that a member of the
research team will contact them in six and twelve months
time to conduct a follow-up interview, receive a £5 vou-
cher and returned to the care of ED staff.
Fidelity
To assess the fidelity of the delivery of the interventions
to the norm we shall record a random sample of 20% of
the interventions delivered by each researcher using the
iPad application. The resulting audio files will not con-
tain personal identifiable data and will be stored separ-
ately from the patient data.
Follow up assessments
All participants will be followed up at 6 months after
randomisation with a brief set of questions and then at
12 months for a full assessment. Follow up interviews will
be conducted over the telephone, face to face or electro-
nically via web survey, as preferred by the participant – by
research assistants trained in the administration of the as-
sessment tools and blinded to the group allocation of the
participants. Letters of thanks will be sent to participants
after each follow up stage. On completion of each follow-
up interview participants will receive a gift token for £5 in
recognition of their participation.Outcome measures
Primary outcome measure
Total alcohol consumed in standard UK units (1 unit =
8 g ethanol) over the 28 days before the 12-month follow-
up, assessed using the Timeline Follow Back interview
28-day version (TLFB28) will be our primary outcome
measure. TLFB28 is an established valid and reliable
method of ascertaining alcohol consumption in adolescent
populations over a reference period ranging from 7 to
365 days [35].
Secondary outcome measures
The TLFB28 will also provide secondary outcomes of
percentage of days abstinent, drinks per drinking day,
and number of days of heavy episodic alcohol use. Par-
ticipants will also be asked questions about alcohol use
over their lifetimes and the past year, and the conse-
quences of alcohol consumption using questions 19, 21,
and 22 from the ESPAD study [5] at baseline. Hazardous
alcohol use will be assessed using the extended AUDIT-C
questionnaire [29] at baseline and after 6 and 12 months.
General health and functioning will be measured using
the Strengths and Difficulties Questionnaire [30] at base-
line and 12 months. We shall also ask about service use
including previous use of health and social services, school
attendance and contact with criminal justice; and health
utility (EQ-5D-5 L; 31) at baseline, 6 and 12 months.
Process outcome measures
Expectancy will be measured using the ESPAD Question
21 [5] at baseline and 12 months after randomisation.
Adherence to the eBI intervention will be assessed by
monitoring remotely either when the smartphone device
is connected to the internet, or else access to the web ap-
plication. To assess treatment fidelity a random sample of
treatment sessions will be audio-recorded, stratified by re-
searcher, intervention, risk group and centre. These will
be assessed for fidelity to behavioural change components
using a behaviour rating scale employed in previous stud-
ies of alcohol brief intervention. Assessment will be con-
ducted by two independent expert clinician assessors and
analysed to take account of agreement between them.
Economic outcome measures
The primary outcome measure for the economic evaluation
in the trial will be the quality adjusted life year (QALY) as
assessed by the EQ-5D-5 L [31]. The secondary economic
outcome measure will be alcohol consumption – derived
from the TLFB28 for the high-risk group and from the
maintainence of low-risk consumption for the low-risk
group. The study will also collect data on the costs of the
interventions and on the use of NHS, social care, criminal
justice and other resources over 12 months follow-up
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Analysis
Sample size calculation
For both studies the sample size addresses the effect of in-
terventions on the primary outcome measure – alcohol
consumption at 12 months after randomisation. To detect
the ‘clinically important’ effect size of 0.3 (that previously
used for adults) with a significance level of 5% and statis-
tical power of 80% when using a two-sided continuity-
corrected test will require 175 in each of the 3 groups,
yielding a target of 525 analysable participants in each of
the two trials.
Predicting that follow-up at 12 months will be 70% we
need to randomise 750 high-risk drinkers and 750 low-
risk drinkers. Based on the estimated prevalence of
24.2% for high-risk drinking (namely AUDIT-C ≥ 3) from
our earlier survey and a consent rate of 60%, we would
need to approach 5165 potential participants over the
recruitment period. Of these our survey predicts that
2,350 will be low-risk drinkers consenting to the study.
Therefore we shall initially sample one third of these to
participate in the study; and we shall adjust this ratio if
necessary.
To assess fidelity we plan to record a random sample of
20% of allocations, stratified by researcher, intervention,
risk group, and centre. This will provide a total sample of
300 – 50 in each of the six intervention groups across for
high and low risks.
Statistical analysis
We shall review our basic design at the end of the internal
pilot study, when we have recruited 100 participants, to
assess recruitment, consenting and adherence. We shall
study the impact of the research on observed screening
and prevalence rates to confirm our design, especially the
number of centres needed in the main trial.
The outcomes for both studies will be analysed in a
similar manner. The primary analysis will be by treat-
ment allocated using a two-sided 5% significance level.
Analysis and results will be presented in accordance with
the CONSORT guidelines. The primary outcome is total
units of alcohol consumed in the 28-days before the 12-
month follow-up. After checking the distributional assump-
tion of normality, and transforming the data if necessary,
we shall conduct multivariate analysis of covariance adjust-
ing for baseline AUDIT-C score, age, gender and centre to
estimate the magnitude of differences between groups.
Analysis will be presented as mean differences between
groups with 95% confidence intervals. Multiple imput-
ation will be employed with sensitivity analysis to adjust
for missing data. Secondary outcomes will be analysed in
a similar manner.Analysis will also model the relationship between pre-
randomisation factors and observed outcomes, including
whether positive or negative at 12 months according to
AUDIT-C. This will take the form of a linear or logistic re-
gression including interaction terms for allocated group.
These models will also assess the effect of adherence and
fidelity of interventions on observed outcomes.
Cost-effectiveness analysis
The clinical effectiveness analysis will be complemented
by an economic evaluation that will estimate the cost-
effectiveness of each intervention versus screening alone.
Alcohol use disorders and associated problems generate
high costs in health care and in society more widely, includ-
ing costs to the criminal justice and social care systems.
The incremental cost effectiveness of the two interven-
tions versus screening will thus be assessed from a societal
perspective that will account for resource savings beyond
the NHS.
The costs of screening and of delivering the two inter-
ventions will be estimated by prospectively monitoring
resource inputs to each arm of the trial, including train-
ing, valued using standard methods [36]. Effects on NHS
and non-NHS costs will be estimated from informa-
tion gathered on patient contact with primary care, sec-
ondary care, specialist health services, social services and
criminal justice. These will be assessed retrospect-
ively using the CSRI tool. Service use will be valued
using local costs where possible supplemented by na-
tional sources and information from previous alcohol
studies [34,37,38].
Cost effectiveness will be assessed in terms of the in-
cremental net health benefit (NHB), which converts
costs and Quality Adjusted Life Years (QALYs) gained,
as estimated from EQ-5D-5 L scores and UK population
utility values, into a single monetary value. Differences
in QALYs will be estimated from the ‘area under the
utility curve’. Both one-way and multi-way sensitivity
analyses will be carried out to explore our basic assump-
tions. Non-parametric bootstrapping will be used to in-
vestigate joint uncertainty in costs and effects via cost
effectiveness acceptability curves.
Three secondary analyses will be undertaken. The first
will adopt a narrower NHS perspective including only
costs and savings relating to the NHS and personal social
services. This will us to compare the NHB with other in-
terventions assessed using the narrower perspective rec-
ommended by the National Institute for Health and Care
Excellence (NICE) for the economic evaluation of NHS in-
terventions. The second will compare total societal costs
with decreased alcohol consumption for the high-risk
group. The third will compare total societal costs with the
proportion of the low-risk group maintaining moderate al-
cohol use.
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To explore acceptability of trial tools and processes to
young people presenting at emergency departments we
shall use semi-structured interviews to study: issues relat-
ing to consent by young people aged 14–17 years; alcohol
screening; the baseline questionnaire and the burden on
emergency care; and young person experiences of inter-
vention delivery. A purposive sample of participants will
be selected from the pool of participants in the two linked
trials for interviews about the experience and acceptability
of receiving the interventions. The sampling will cover the
key variables of interest including: gender; ethnicity; age;
level of alcohol use; area of the country (North East,
Yorkshire and Humber or London), allocated interven-
tion and whether it was delivered. To achieve this, a sam-
ple of at least 20 young people is likely to be required.
However, recruitment will continue until data saturation
is deemed to have been achieved, that is no new issues or
themes are arising in the interviews.
A participant information leaflet explaining the quali-
tative study will be sent to a sample of young people
who provided consent to be contacted for interview and,
when appropriate, their parents. The young people will
be invited to attend a one-to-one semi-structured inter-
view. The interviews will be conducted in a venue that is
appropriate, taking consideration of confidentiality, risk
assessment, participant convenience and comfort. The
purpose of the interview will be explained orally to the
participant before arranging interview time and date.
Interviews will be audio-recorded and transcribed to
support data analysis. Though the topic guide will be pro-
duced before the start of interviews, and state the aims
and objectives of the study, emergent issues will be ex-
plored as they arise.
Data will be subjected to framework analysis, which is
appropriate for qualitative health research with objec-
tives linked to quantitative investigation. This analytic
strategy is characterised by an approach more deductive
than inductive, in which analysis is structured around
given themes so findings have detailed relevance to ap-
plied research questions. Based on interview notes and
review of the interview recordings, important or recur-
rent themes in interviewees’ responses will be identified.
These will be combined with a list of key themes of re-
search interest derived from the aims and objectives of the
study. All transcripts will be repeatedly read and coded
within this framework of prior headings. Data coded
under each heading will be reviewed to produce a detailed
description, and revised through the course of analysis to
take account of all material under that heading. Finally the
descriptions of headings within the framework will be
compared and the relationships between them elaborated
to provide a consistent interpretation of the dataset as a
whole. Analysis will continue throughout the process ofdata collection, and will be discussed within the subgroup
of the research team tasked with managing the qualitative
study. This analytic process will assist in the identification
of emerging themes and enhance credibility of the the-
matic framework and interpretation.
Discussion
This protocol represents an innovative and ambitious
programme of work evaluating the use of novel interven-
tions to address alcohol use in adolescent populations. The
study addresses both effectiveness and cost-effectiveness
and is designed to provide evidence of what works in redu-
cing at-risk drinking in this population in addition to how
to reduce the progression from low to high risk drinking.
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